THE
CCP Film, Broadcast and New Media Division now accepts entries for the Ika-31
Gawad CCP Para sa Alternatibong Pelikula at Video. Deadline for submission is on or before March
15, 2019 (Friday), not later than 6:00 p.m. at the CCP FBNMD Office, located at
the 4/F CCP Main Building.
Entries
must include a duly accomplished entry form, which can be downloaded at
www.culturalcenter.gov.ph or www.cinemalaya.org; one (1) digital data file of
the entry in full resolution (saved on USB or burned on a DVD as data with file
properly labelled or identified); and one (1) DVD or USB containing the
synopsis, genre, running time, rating, production credits, two (2) black &
white photos from the film entry in jpeg format, and film entry poster (if
available) in jpeg format.
Interested
participants can submit a maximum of three (3) entries in each category, but an
entry can only be submitted in one (1) category. Categories include Short Feature/Narrative,
Experimental, Documentary, and Animation.
The
selected entries will be screened during the Ika-31 Gawad CCP Para sa
Alternatibong Pelikula at Video Festival on August 3-5, 2019 as part of the
15th Cinemalaya Philippine Independent Film Festival, which is slated from August
2 to 11, 2019 at the CCP theaters and various venues.
The
best films will be awarded during the Awards Night on August 5, 2019 at the CCP
Tanghalang Manuel Conde (Dream Theater). Winning entries in each category will
receive P25,000.00 (1st Prize), P15,000.00 (2nd Prize), and P10,000.00 (3rd Prize). An Honorable Mention awardee will also get P5,000.00.
This year, Special Awards include: Best Regional Entry and Best Entry
On/For/By Children.
Now
on its 31st year of annually citing the country’s most outstanding film and
video artists, the Gawad Alternatibo (for short) is considered the
longest-running independent film and video competition in Asia.
For
entry forms and complete guidelines, visit www.cinemalaya.org,
www.culturalcenter.gov.ph or call the CCP FBNMD Office at 832-1125, local 1705
& 1712.
No comments:
Post a Comment